TSE:SLF

Sun Life Financial Inc (SLF.TO)

113.00
+0.04 (0.04%)
as of Jul 3, 2026, 8:00:00 pm Market Open.
718 watching
0
Investor Insights
star iconJul 5, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Sun Life Financial Inc. (SLF) has received mixed reviews from various experts, with some pointing out its solid fundamentals and growth potential, particularly in Asian asset management. While the company reported a decent quarter, challenges persist in its asset management segment and the U.S. dental business due to uncertainties regarding Medicaid funding. Valuations appear attractive compared to Canadian banks, trading at 11.7x PE and a yield of approximately 4.5%. Experts appreciate SLF's focus on dividends and its healthy ROE, though some express caution regarding its range-bound performance with MFC gaining more attention in the insurance sector. The general view is to hold onto the stock for the long term, despite current headwinds in growth and profitability in certain segments.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
MFC
BUY
A good company. Like most of the insurance companies right now.
BUY
Life companies are good for core holdings. A good company.
HOLD
Likes it for the long term. Prefers Manulife.
BUY
Likes.
WAIT
Likes the insurers in general. Have full confidence in the management, but wait to see what happens regarding the SEC civil action.
BUY ON WEAKNESS
Has really good technical structure. May by reaching a resistance level. Buy on any dip below $30/29.
PAST TOP PICK
(A past top pick Sept 26/03. Up 7.3%.)News out of the US has put a damper on the stock bringing it into more interesting ranges. A good long-term play.
BUY
Controversy on their US mutual fund assets has held the price down. Probably a good time to get in. Has successfully integrated their acquisition Clarica. 2.2% dividend yield.
BUY
Prefers this and Industrial Alliance over other insurance companies. Leverage to capital markets through mutual funds.
DON'T BUY
Likes the prospects for long-term. Good business strategy. In the intermediate term, from a fair market value view, is pretty fully priced. Would have to be substantially lower before buying.
BUY
Not a bad stock. Prefers ManuLife.
DON'T BUY
Expect this stock to stay quiet for a time. Good company. Well run.
BUY
Likes the prospect for this company. Has been very astute in turning their assets and growing them. Valuation looks OK.
TOP PICK
Prefers Lifecos to banks because they have more to gain from strong capital markets. Financials are a good place to be in the event the market hits some headwinds.
DON'T BUY
Well-positioned in the Canadian market and looking to grow through US acquisitions. Prefers banks in the financial sector.
Showing 841 to 855 of 1,049 entries